Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural basis for the activation of acid ceramidase
A. Gebai, A. Gorelik, Zixian Li, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Lysosomal Glycosphingolipid Storage Diseases
Bernadette Breiden, Konrad Sandhoff
Annual Review of Biochemistry (2019) Vol. 88, Iss. 1, pp. 461-485
Closed Access | Times Cited: 127
Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction
Yoav Hadas, Adam Vincek, Elias Youssef, et al.
Circulation (2020) Vol. 141, Iss. 11, pp. 916-930
Open Access | Times Cited: 124
Acid ceramidase deficiency: Farber disease and SMA-PME
Fabian P. S. Yu, Samuel Amintas, Thierry Levade, et al.
Orphanet Journal of Rare Diseases (2018) Vol. 13, Iss. 1
Open Access | Times Cited: 118
Spatial proteomics in three-dimensional intact specimens
Harsharan S. Bhatia, Andreas‐David Brunner, Furkan Öztürk, et al.
Cell (2022) Vol. 185, Iss. 26, pp. 5040-5058.e19
Open Access | Times Cited: 67
Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology
Rama Jamjoum, Saurav Majumder, Batoul M. Issleny, et al.
Frontiers in Physiology (2024) Vol. 14
Open Access | Times Cited: 11
Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur
Alexey Dementiev, A. Joachimiak, Ha Nguyen, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 2, pp. 987-992
Open Access | Times Cited: 67
N-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition
Daniele Piomelli, Laura Scalvini, Yannick Fotio, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 14, pp. 7475-7490
Open Access | Times Cited: 67
Proteomics quantifies protein expression changes in a model cnidarian colonised by a thermally tolerant but suboptimal symbiont
Ashley E. Sproles, Clinton A. Oakley, J. L. Matthews, et al.
The ISME Journal (2019) Vol. 13, Iss. 9, pp. 2334-2345
Open Access | Times Cited: 66
Metabolism of Glycosphingolipids and Their Role in the Pathophysiology of Lysosomal Storage Disorders
Alex E. Ryckman, Inka Brockhausen, Jagdeep S. Walia
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6881-6881
Open Access | Times Cited: 51
Identification and Characterization of Polysorbate-Degrading Enzymes in a Monoclonal Antibody Formulation
Tobias Graf, Anthony A. G. Tomlinson, Inn H. Yuk, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 110, Iss. 11, pp. 3558-3567
Open Access | Times Cited: 45
An intestinal sphingolipid confers intergenerational neuroprotection
Wenyue Wang, Tessa Sherry, Xinran Cheng, et al.
Nature Cell Biology (2023) Vol. 25, Iss. 8, pp. 1196-1207
Open Access | Times Cited: 17
Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance
Ha Son Nguyen, Saman Shabani, Ahmed J. Awad, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 6, pp. 1765-1765
Open Access | Times Cited: 52
The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane
Michal Stark, Tomás F. D. Silva, Guy Levin, et al.
Cells (2020) Vol. 9, Iss. 5, pp. 1082-1082
Open Access | Times Cited: 45
Lipids as Emerging Biomarkers in Neurodegenerative Diseases
Justin Wei, Li Chin Wong, Sebastian Boland
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 131-131
Open Access | Times Cited: 14
Acid Ceramidase Deficiency
Silvestre Cuinat, Paul Rollier, Katheryn Grand, et al.
Neurology Genetics (2025) Vol. 11, Iss. 2
Closed Access
Molecular mechanism of activation of the immunoregulatory amidase NAAA
A. Gorelik, A. Gebai, Katalin Illes, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 43
Open Access | Times Cited: 43
Structure of a human intramembrane ceramidase explains enzymatic dysfunction found in leukodystrophy
Ieva Vasiliauskaité-Brooks, Robert D. Healey, Pascal Rochaix, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 43
Structure of a human intramembrane ceramidase explains enzymatic dysfunction found in leukodystrophy.
Ieva Vasiliauskaité-Brooks, Robert D. Healey, Pascal Rochaix, et al.
Nature Communications (2018) Vol. 9, Iss. 1, pp. 5437-5437
Closed Access | Times Cited: 39
Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe disease
Judith Lang, Patrick Bohn, Hilal Bhat, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 37
Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions
Annie Kleynerman, Jitka Rybová, Mary L. Faber, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 274-274
Open Access | Times Cited: 11
Cutting Edge of the Pathogenesis of Atopic Dermatitis: Sphingomyelin Deacylase, the Enzyme Involved in Its Ceramide Deficiency, Plays a Pivotal Role
Genji Imokawa
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1613-1613
Open Access | Times Cited: 26
Acid ceramidase controls apoptosis and increases autophagy in human melanoma cells treated with doxorubicin
Michele Lai, Rachele Amato, Veronica La Rocca, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 25
The Human Ntn-Hydrolase Superfamily: Structure, Functions and Perspectives
Arne Linhorst, Torben Lübke
Cells (2022) Vol. 11, Iss. 10, pp. 1592-1592
Open Access | Times Cited: 16
Identification of CERS5 as a molecular biomarker in pan-cancer through multiple omics integrative analysis
Shengyu Wang, Jian Yang, Weijia Huang, et al.
Cellular Signalling (2024) Vol. 116, pp. 111054-111054
Open Access | Times Cited: 3
Ceramide Metabolism Enzymes—Therapeutic Targets against Cancer
Ana Gómez-Larrauri, Upasana Das Adhikari, Marta Aramburu-Núñez, et al.
Medicina (2021) Vol. 57, Iss. 7, pp. 729-729
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top